D. Antoniou

455 total citations
15 papers, 359 citations indexed

About

D. Antoniou is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, D. Antoniou has authored 15 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in D. Antoniou's work include Lung Cancer Research Studies (10 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer therapeutics and mechanisms (4 papers). D. Antoniou is often cited by papers focused on Lung Cancer Research Studies (10 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer therapeutics and mechanisms (4 papers). D. Antoniou collaborates with scholars based in Greece, Romania and China. D. Antoniou's co-authors include George P. Stathopoulos, J. Dimitroulis, J. Stathopoulos, M. Veslemes, Niki Georgatou, Ioannis Karydis, M. Toubis, Dimitrios Veldekis, D. Tsavdaridis and S. Rigatos and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

D. Antoniou

15 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Antoniou Greece	8	180	140	110	103	80	15	359
Adrianus C. Laan Netherlands	13	145 0.8×	85 0.6×	50 0.5×	155 1.5×	71 0.9×	20	439
Rosemary R. Palmer United Kingdom	4	76 0.4×	109 0.8×	80 0.7×	49 0.5×	83 1.0×	6	495
A. Antón Torres Spain	8	301 1.7×	190 1.4×	71 0.6×	76 0.7×	57 0.7×	33	525
Daniël Ernst Chile	9	145 0.8×	77 0.6×	17 0.2×	106 1.0×	148 1.9×	21	488
Veronika Ecker Germany	8	149 0.8×	62 0.4×	64 0.6×	180 1.7×	46 0.6×	12	404
Tong Yang China	10	53 0.3×	57 0.4×	41 0.4×	79 0.8×	113 1.4×	28	289
Yusuke Ohara Japan	11	198 1.1×	68 0.5×	95 0.9×	152 1.5×	80 1.0×	53	465
J. Sigmond Netherlands	11	193 1.1×	149 1.1×	17 0.2×	185 1.8×	18 0.2×	15	419
Ephraem Leitner Australia	7	34 0.2×	39 0.3×	45 0.4×	126 1.2×	98 1.2×	8	340
Hongying Su China	11	96 0.5×	35 0.3×	39 0.4×	120 1.2×	66 0.8×	21	358

Countries citing papers authored by D. Antoniou

Since Specialization

Citations

This map shows the geographic impact of D. Antoniou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Antoniou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Antoniou more than expected).

Fields of papers citing papers by D. Antoniou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Antoniou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Antoniou. The network helps show where D. Antoniou may publish in the future.

Co-authorship network of co-authors of D. Antoniou

This figure shows the co-authorship network connecting the top 25 collaborators of D. Antoniou. A scholar is included among the top collaborators of D. Antoniou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Antoniou. D. Antoniou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Stathopoulos, George P., et al.. (2011). Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 68(4). 945–950. 83 indexed citations

2.

Stathopoulos, George P., D. Antoniou, J. Dimitroulis, et al.. (2010). Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial. Annals of Oncology. 21(11). 2227–2232. 90 indexed citations

3.

Antoniou, D., et al.. (2010). Role of quantitative CT in predicting postoperative FEV1 and chronic dyspnea in patients undergoing lung resection. Multidisciplinary Respiratory Medicine. 5(3). 188–188. 8 indexed citations

4.

Antoniou, D., et al.. (2010). Comparison of response rate of advanced non-small lung cancer patients to liposomal cisplatin versus cisplatin both combined with paclitaxel: A phase III trial.. Journal of Clinical Oncology. 28(15_suppl). 7579–7579. 1 indexed citations

5.

Antoniou, D., et al.. (2010). Role of quantitative CT in predicting postoperative FEV1 and chronic dyspnea in patients undergoing lung resection. Multidisciplinary Respiratory Medicine. 5. 1 indexed citations

6.

Stathopoulos, George P., Alexandros Ardavanis, Pavlos Papakotoulas, et al.. (2009). Myelotoxicity of oral topotecan in relation to treatment duration and dosage: a phase I study. Anti-Cancer Drugs. 21(2). 202–205. 7 indexed citations

7.

Stathopoulos, G., et al.. (2007). Liposomal cisplatin and paclitaxel versus cisplatin and paclitaxel in advanced NSCLC. Journal of Clinical Oncology. 25(18_suppl). 7684–7684. 1 indexed citations

8.

Antoniou, D., et al.. (2006). Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer. Lung Cancer. 53(2). 205–210. 61 indexed citations

9.

Dimitroulis, J., M. Toubis, D. Antoniou, et al.. (2006). Alternate paclitaxel-gemcitabine and paclitaxel-vinorelbine biweekly administration in non-small cell lung cancer patients: a phase II study.. PubMed. 26(2B). 1397–402. 4 indexed citations

10.

Stathopoulos, George P., et al.. (2005). Front-line paclitaxel and irinotecan combination chemotherapy in advanced non-small-cell lung cancer: a phase I–II trial. British Journal of Cancer. 93(10). 1106–1111. 20 indexed citations

11.

Stathopoulos, George P., J. Stathopoulos, D. Skarlos, et al.. (2005). Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel: a phase II study. Cancer Chemotherapy and Pharmacology. 57(6). 796–800. 12 indexed citations

12.

Antoniou, D., et al.. (2005). Response to radiotherapy in brain metastases and survival of patients with non-small cell lung cancer. Oncology Reports. 14(3). 733–6. 9 indexed citations

13.

Veslemes, M., et al.. (2005). Phase II study of cisplatin-combined schedules as second-line chemotherapy in patients with non-small cell lung cancer.. PubMed. 25(4). 2991–6. 5 indexed citations

14.

Antoniou, D., George P. Stathopoulos, S. Rigatos, et al.. (2005). Mesothelioma: treatment and survival of a patient population and review of the literature.. PubMed. 25(5). 3671–6. 7 indexed citations

15.

Stathopoulos, George P., M. Veslemes, Niki Georgatou, et al.. (2004). Front-line paclitaxel–vinorelbine versus paclitaxel–carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trial. Annals of Oncology. 15(7). 1048–1055. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact